Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Aclaris Therapeutics, Inc. | StockGist | StockGist

Companies
ACRS
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ACRSSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Aclaris Therapeutics, Inc.

Filed Feb 9, 2026

Accepted Feb 9, 2026, 12:00 AM ET

CIK 0001557746

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Aclaris Therapeutics, Inc.

Person Type

PN

CUSIP: 00461U105

Recent Filings

Aclaris Therapeutics, Inc.1 weeks ago

Aclaris Therapeutics, Inc.3 weeks ago

Aclaris Therapeutics, Inc.4 weeks ago

Aclaris Therapeutics, Inc.1 months ago

Aclaris Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice